Categories AlphaGraphs, Earnings, Industrials
Paychex’s (PAYX) Q4 earnings and revenue decreases, but exceeds estimates
Paychex (NASDAQ: PAYX) reported fourth quarter 2020 earnings results. Adjusted earnings of $0.61 per share and revenue of $915.1 million decreased year-over-year. However, the company’s bottom and top-line results surpassed market’s view.
For FY21, Paychex expects adjusted EPS to decline in the range of 6% to 10% and revenue to decline in the range of 2% to 5%.
Paychex stock, which decreased 9% so far this year, inched up immediately after the earnings announcement and then declined about 1% in the before market trading hours.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
